Johnson & Johnson Could Serve As High-Yield Bond Alternative

Analyst Background and Focus - The analyst specializes in high-quality companies with competitive advantages (economic moat) and high defensibility, focusing on long-term market outperformance [1] - The analyst's coverage includes European and North American companies across all market capitalizations, from large-cap to small-cap [1] - The analyst holds a Master's Degree in Sociology with a focus on organizational and economic sociology, and a Bachelor's Degree in Sociology and History [1] Previous Analysis and Outlook - The analyst published a previous article on Johnson & Johnson (JNJ) in July 2024, rating the stock as a "Buy" due to optimism about the company's business [1] Disclosure and Position - The analyst holds a beneficial long position in Gilead Sciences (GILD) through stock ownership, options, or other derivatives [2] - The article represents the analyst's personal opinions and is not influenced by compensation or business relationships with the mentioned companies [2]